A Multi-centre, Randomised, Parallel, Open Labelled Study to Compare the Efficiency and Safety Profile of Insulin Aspart (NovoRapid) and Human Soluble Insulin (Novolin R) as Meal Related Insulin in a Three Times Daily Regimen With One Injection of Novolin N at Bedtime in Chinese Type 1 and 2 Diabetics.
Phase of Trial: Phase IV
Latest Information Update: 24 Dec 2016
At a glance
- Drugs Insulin aspart (Primary) ; Insulin
- Indications Diabetes mellitus; Type 1 diabetes mellitus; Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Novo Nordisk
- 31 Aug 2018 Biomarkers information updated
- 24 May 2012 Official Title amended as reported by ClinicalTrials.gov.
- 18 Jan 2008 New trial record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History